Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aiming Liu

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Chemical Research in Toxicology|December 24, 2010
Biphasic regulation of intracellular calcium by gemfibrozil contributes to inhibiting L6 myoblast differentiation: implications for clinical myotoxicityAiming Liu, Julin Yang, Frank J Gonzalez, et al.
International Journal of Molecular Medicine|October 30, 2020
Inhibition of inflammation by SP600125 in cholestatic liver injury is dependent on the administration‑based exposure profileXiuting Zheng, Manyun Dai, Gangming Xu, et al.
Phytotherapy Research : PTR|November 25, 2011
Drug-drug interactions between ketoconazole and berberine in rats: pharmacokinetic effects benefit pharmacodynamic synergismYanmi Zhou, Ping He, Aiming Liu, et al.
Molecular Medicine Reports|July 7, 2020
Cholestatic models induced by lithocholic acid and α‑naphthylisothiocyanate: Different etiological mechanisms for liver injury but shared JNK/STAT3 signalingGangming Xu, Manyun Dai, Xiuting Zheng, et al.
Toxicology and Applied Pharmacology|January 20, 2009
Myotoxicity of gemfibrozil in cynomolgus monkey model and its relationship to pharmacokinetic propertiesAiming Liu, Shuilin Xie, He Sun, et al.
Molecular Medicine Reports|November 15, 2021
Promoter CAG is more efficient than hepatocyte‑targeting TBG for transgene expression via rAAV8 in liver tissuesJinyu Kang, Lujie Huang, Wentao Zheng, et al.
Biopharmaceutics & Drug Disposition|September 26, 2017
Species-related exposure of phase II metabolite gemfibrozil 1-O-β-glucuronide between human and mice: A net induction of mouse P450 activity was revealedMin Luo, Manyun Dai, Hante Lin, et al.
Journal of Ethnopharmacology|April 30, 2025
Gut-vascular barrier mediated Tripterygium wilfordii-induced liver injury: the synergism between triptolide and celastrol via intestinal FXR-ET-1 pathwayManyun Dai, Wan Peng, Binbin Zhang, et al.
BMC Endocrine Disorders|November 28, 2025
Metabolically healthy obesity increases the risks of MASLD and hyperuricemia: a cohort study with mediation analysisYiyun Liu, Tianchen Qian, Yiyang Zheng, et al.
BMC Pulmonary Medicine|November 18, 2023
Impacts of short-term low-level exposure to air pollutants on hospital admissions for pulmonary sepsis in elderly patientsJing Chen, Aiming Liu, JunJie Dai, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Chemical Research in Toxicology|December 24, 2010
Biphasic regulation of intracellular calcium by gemfibrozil contributes to inhibiting L6 myoblast differentiation: implications for clinical myotoxicityAiming Liu, Julin Yang, Frank J Gonzalez, et al.
International Journal of Molecular Medicine|October 30, 2020
Inhibition of inflammation by SP600125 in cholestatic liver injury is dependent on the administration‑based exposure profileXiuting Zheng, Manyun Dai, Gangming Xu, et al.
Phytotherapy Research : PTR|November 25, 2011
Drug-drug interactions between ketoconazole and berberine in rats: pharmacokinetic effects benefit pharmacodynamic synergismYanmi Zhou, Ping He, Aiming Liu, et al.
Molecular Medicine Reports|July 7, 2020
Cholestatic models induced by lithocholic acid and α‑naphthylisothiocyanate: Different etiological mechanisms for liver injury but shared JNK/STAT3 signalingGangming Xu, Manyun Dai, Xiuting Zheng, et al.
Toxicology and Applied Pharmacology|January 20, 2009
Myotoxicity of gemfibrozil in cynomolgus monkey model and its relationship to pharmacokinetic propertiesAiming Liu, Shuilin Xie, He Sun, et al.
Molecular Medicine Reports|November 15, 2021
Promoter CAG is more efficient than hepatocyte‑targeting TBG for transgene expression via rAAV8 in liver tissuesJinyu Kang, Lujie Huang, Wentao Zheng, et al.
Biopharmaceutics & Drug Disposition|September 26, 2017
Species-related exposure of phase II metabolite gemfibrozil 1-O-β-glucuronide between human and mice: A net induction of mouse P450 activity was revealedMin Luo, Manyun Dai, Hante Lin, et al.
Journal of Ethnopharmacology|April 30, 2025
Gut-vascular barrier mediated Tripterygium wilfordii-induced liver injury: the synergism between triptolide and celastrol via intestinal FXR-ET-1 pathwayManyun Dai, Wan Peng, Binbin Zhang, et al.
BMC Endocrine Disorders|November 28, 2025
Metabolically healthy obesity increases the risks of MASLD and hyperuricemia: a cohort study with mediation analysisYiyun Liu, Tianchen Qian, Yiyang Zheng, et al.
BMC Pulmonary Medicine|November 18, 2023
Impacts of short-term low-level exposure to air pollutants on hospital admissions for pulmonary sepsis in elderly patientsJing Chen, Aiming Liu, JunJie Dai, et al.
Pageof 8